Indications and contraindications of dental implants in medically compromised patients: update

Rafael Gómez-de Diego, María del Rocío Mang-de la Rosa, María-Jesús Romero-Pérez, Antonio Cutando-Soriano, Antonio López-Valverde-Centeno, Rafael Gómez-de Diego, María del Rocío Mang-de la Rosa, María-Jesús Romero-Pérez, Antonio Cutando-Soriano, Antonio López-Valverde-Centeno

Abstract

The aim of this study was to review the current scientific literature in order to analyse the indications and contraindications of dental implants in medically compromised patients. A reference research was carried out on PubMed using the key words "implant" AND (oral OR dental) AND (systemic disease OR medically compromised), in articles published between 1993 and 2013. The inclusion criteria were the following: clinical studies in which, at least, 10 patients were treated, consensus articles, reviewed articles and meta-analysis performed in humans treated with dental implants, and which included the disease diagnosis. A total of 64 articles were found, from which 16 met the inclusion criteria. Cardiac systemic diseases, diabetic endocrine pathologies or controlled metabolic disorders do not seem to be a total or partial contraindication to the placement of dental implants. Tobacco addiction, and head and neck radiotherapy are correlated to a higher loss of dental implants. Patients suffering from osteoporosis undergoing biphosphonates therapy show an increased risk of developing bone necrosis after an oral surgery, especially if the drugs are administered intravenously or they are associated to certain concomitant medication.

References

    1. Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med. 2003;14:305–16.
    1. Saklad M. Granding of patients for surgical procedures. Anesthesiol. 1941;2:281–4.
    1. McCarthy FM, Malamed SF. Physical evaluation system to determinate medical risk and indicated dental therapy modifications. J Am Dent Assoc. 1979;99:181–4.
    1. Dios PD, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent. Forthcoming 2013.
    1. Scully C, Hobkirk J, Dios PD. Dental endosseous implants in the medically compromised patient. J Oral Rehabil. 2007;34:590–9.
    1. Lee HJ, Kim YK, Park JY, Kim SG, Kim MJ, Yun PY. Short-term clinical retrospective study of implants in geriatric patients older than 70 years. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:442–6.
    1. Bornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for implant therapy. Int J Oral Maxillofac Implants. 2009;24 Suppl:12–27.
    1. Hwang D, Wang HL. Medical contraindications to implant therapy: Part II: Relative contraindications. Implant Dent. 2007;16:13–23.
    1. Khadivi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with osseointegration surgery. J Prosthet Dent. 1999;81:533–6.
    1. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implants Res. 2008;19:670–6.
    1. Esposito M, Grusovin MG, Patel S, Worthington HV, Coulthard P. Interventions for replacing missing teeth: Hyperbaric oxygen therapy for irradiated patients who require dental implants. Cochrane Database Syst Rev. 2008:CD003603.
    1. Verdonck HW, Meijer GJ, Laurin T, Nieman FH, Stoll C, Riediger D. Implant stability during osseointegration in irradiated and non-irradiated minipig alveolar bone: an experimental study. Clin Oral Implants Res. 2008;19:201–6.
    1. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol. 1999;70:724–9.
    1. Susarla SM, Chuang SK, Dodson TB. Delayed versus immediate loading of implants: Survival analysis and risk factors for dental implant failure. J Oral Maxillofac Surg. 2008;66:251–5.
    1. Holahan CM, Koka S, Kennel KA, Weaver AL, Assad DA, Regennitter FJ. Effect of osteoporotic status on the survival of titanium dental implants. Int J Oral Maxillofac Implants. 2008;23:905–10.
    1. Sverzut AT, Stabile GA, de Moraes M, Mazzonetto R, Moreira RW. The influence of tobacco on early dental implant failure. J Oral Maxillofac Surg. 2008;66:1004–9.
    1. Lee JY, Park HJ, Kim JE, Choi YG, Kim YS, Huh JB. A 5-year retrospective clinical study of the Dentium implants. J Adv Prosthodont. 2011;3:229–35.
    1. Alsaadi G, Quirynen M, Michiles K, Teughels W, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J Clin Periodontol. 2008;35:51–7.
    1. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol. 2007;34:610–7.
    1. McCracken M, Lemons JE, Rahemtulla F, Prince CW, Feldman D. Bone response to titanium alloy implants placed in diabetic rats. Int J Oral Maxillofac Implants. 2000;15:345–54.
    1. Fiorellini JP, Nevins ML, Norkin A, Weber HP, Karimbux NY. The effect of insulin therapy on osseointegration in a diabetic rat model. Clin Oral Implants Res. 1999;10:362–68.
    1. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: Placement to 36 months. Ann Periodontol. 2000;5:157–65.
    1. Mombelli A, Cionca N. Systemic diseases affecting osseointegration therapy. Clin Oral Implants Res. 2006;17:97–103.
    1. Michaeli E, Weinberg I, Nahlieli O. Dental implants in the diabetic patient: systemic and rehabilitative considerations. Quintessence Int. 2009;40:639–45.
    1. Blanchaert RH. Implants in the medically challenged patient. Dent Clin North Am. 1998;42:35–45.
    1. de Melo L, Piattelli A, Lezzi G, d'Avila S, Zenóbio EG, Shibli JA. Human histologic evaluation of a six-year-old threaded implant retrieved from a subject with osteoporosis. J Contemp Dent Pract. 20081;9:99–105.
    1. Shibli JA, Aguiar KC, Melo L, d´Avila S, Zenobio EG, Faveri M. Histological comparison between implants retrieved from patients with and without osteoporosis. Int J Oral Maxillofac Surg. 2008;37:321–7.
    1. Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal. 2007;12:E336–40.
    1. Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc. 2009;37:39–42.
    1. Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants. 2006;21:349–53.
    1. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol. 2007;78:1664–9.
    1. Grant B, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg. 2008;66:223–30.
    1. Bell BM, Bell RE. Oral bisphosphonates and dental implants: A retrospective study. J Oral Maxillofac Surg. 2008;66:1022–4.
    1. Koka S, Babu NMS, Norell A. Survival of dental implants in post-menopausal bisphosphonate users. J Prosthodont Res. 2010;54:108–11.
    1. Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A. Implant placement in patients with oral bisphosphonate therapy: A case series. Clin Implant Dent Relat Res. 2010;12:175–80.
    1. Zahid TM, Wang B, Cohen RE. Influence of bisphosphonates on alveolar bone loss around osseointegrated implants. J Oral Implantol. 2011;37:335–46.
    1. Memon S, Weltman RL, Katancik JA. Oral bisphosphonates: Early endosseous dental implant success and crestal bone changes. A retrospective study. Int J Oral Maxillofac Implants. 2012;27:1216–22.
    1. Liddelow G, Klineberg I. Patient-related risk factors for implant therapy. A critique pertinent literature. Aust Dent J. 2011;56:417–26.
    1. Scully C, Madrid C, Bagan J. Dental endosseous implants in patients on bisphosphonate therapy. Implant Dent. 2006;15:212–8.
    1. Siddiqi A, Payne AG, Zafar S. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:E1–8.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner